Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Precipio Inc PRPO

Healthcare
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through... see more

Recent & Breaking News (NDAQ:PRPO)

Precipio To Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time

GlobeNewswire November 16, 2017

Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director

GlobeNewswire November 14, 2017

Precipio, Inc. Announces Closing of $2,748,000 Registered Direct Offering

GlobeNewswire November 13, 2017

Precipio, Inc. Announces Pricing Of $2,748,000 Registered Direct Offering

Accesswire November 3, 2017

Precipio Announces Completion of Substantial Balance Sheet Restructuring

Accesswire November 1, 2017

Precipio's ICE-COLD PCR(TM) Technology Selected by Methodist Healthcare System as Their Liquid Biopsy Platform

Accesswire November 1, 2017

Precipio Receives First Ice Cold- Pcr(TM) Kit Order From Clearbridge Health

Accesswire October 31, 2017

Precipio Delivers First ICE COLD-PCR(TM) Order To New Brazilian Distributor

Accesswire October 26, 2017

Precipio's ICE COLD-PCR(TM) Technology Selected by the University of Kentucky for Liquid Biopsy Study

Accesswire October 17, 2017

Precipio Launches Its First Re-Designed ICE-COLD PCR(TM) Targeted Enrichment Kit To Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies

Accesswire October 12, 2017

Precipio Re-Launches All CLIA Lab and Pharmacological Research Projects at its New Haven, CT Facility

Accesswire October 10, 2017

Precipio Elects Jeffrey Cossman, MD, and Douglas Fisher, MD to its Board of Directors

Accesswire October 2, 2017

Precipio Provides Shareholder Update Letter

Accesswire September 6, 2017

Precipio, Inc. Announces Closing of Public Offering

Accesswire August 31, 2017

Mid-Afternoon Market Update: Crude Oil Up Over 1%; Express Shares Rise After Strong Q2 Results

Benzinga.com  August 23, 2017

15 Biggest Mid-Day Losers For Wednesday

Benzinga.com  August 23, 2017

Mid-Morning Market Update: Markets Open Lower; Lowe's Earnings Miss Expectations

Benzinga.com  August 23, 2017

Precipio, Inc. Prices $6,000,000 Public Offering

Accesswire August 23, 2017

15 Biggest Mid-Day Losers For Friday

Benzinga.com  August 18, 2017

Mid-Afternoon Market Update: Crude Oil Down 2.5%; Horizon Global Shares Spike Higher

Benzinga.com  August 1, 2017